RNAlead is committed to providing pharma, biotech or academic research teams with access to its unique, proprietary RNA delivery technology, FlashRNA®.
FlashRNA® technology is a patented RNA vector with over 10+ years of proven expertise. It is a disruptive, proprietary alternative to LNPs compatible with different and large RNA payloads.
FlashRNA® is an advanced RNA delivery technology, enabling efficient and safe RNA transfer for gene therapy, genome editing, cell reprogramming, mRNA vaccines, and regenerative medicine. It offers unrivaled performance and safety for multiple RNA delivery, in vitro, in vivo and it’s ready for therapy, thanks to a validated GMP scale-up.
RNAlead can provide technological licensing, research-grade FlashRNA® particles, technical support and tech transfer to CDMO for GMP-grade products.
We support our clients throughout their innovation journey, from early-stage research to clinical applications.